Logistics giant DHL and professional services firm Accenture developing blockchain prototype for tracking pharmaceuticals supply chain to eliminate counterfeit drugs

Briefing

Logistics giant DHL and professional services firm Accenture developing blockchain prototype for tracking pharmaceuticals supply chain to eliminate counterfeit drugs

April 25, 2018

Briefing

  • Pharmaceuticals Supply Chain Blockchain – Logistics firm DHL and professional services company Accenture released report on blockchain technology prototype for tracking pharmaceuticals supply chain, from development of medicines to reaching customers
  • Features – Has nodes in six geographies for tracking pharmaceuticals across global supply chain, and can handle more than seven billion unique serial numbers and 1,500 transactions per second
  • Shareable Across Stakeholders – Can be shared among stakeholders, including manufacturers, warehouses, distributors, pharmacies, hospitals, and doctors
  • Addressing Drug Counterfeit – Aims to address proliferation of counterfeit drugs, which causes one million deaths per year, and makes up 30% of pharmaceuticals sold in emerging markets
  • Advantages – Reduces tampering and error, while promoting greater drug safety and lower costs
  • Other Blockchain Solutions – Report also explores blockchain use for asset management to improve transparency and traceability, as well as smart contracts which automatically facilitate and verify contracts without third parties

Accelerator

Market Disruption

Business Model and Practices

Business Model
and Practices

Sector

Healthcare/Health Sciences

Organization

DHL International GmbH

Source

Original Publication Date

March 12, 2018

Leave a comment